PT999849E - Utilizacao de lbp no tratamento da septicemia - Google Patents
Utilizacao de lbp no tratamento da septicemiaInfo
- Publication number
- PT999849E PT999849E PT98928139T PT98928139T PT999849E PT 999849 E PT999849 E PT 999849E PT 98928139 T PT98928139 T PT 98928139T PT 98928139 T PT98928139 T PT 98928139T PT 999849 E PT999849 E PT 999849E
- Authority
- PT
- Portugal
- Prior art keywords
- lbp
- septicemia
- treatment
- utilization
- therapeutic agent
- Prior art date
Links
- 206010040047 Sepsis Diseases 0.000 title abstract 2
- 208000013223 septicemia Diseases 0.000 title abstract 2
- 102000052508 Lipopolysaccharide-binding protein Human genes 0.000 abstract 5
- 108010053632 Lipopolysaccharide-binding protein Proteins 0.000 abstract 5
- 239000003814 drug Substances 0.000 abstract 3
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 241001529936 Murinae Species 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19729810A DE19729810C2 (de) | 1997-07-11 | 1997-07-11 | Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT999849E true PT999849E (pt) | 2003-01-31 |
Family
ID=7835437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98928139T PT999849E (pt) | 1997-07-11 | 1998-04-04 | Utilizacao de lbp no tratamento da septicemia |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6949512B1 (enExample) |
| EP (1) | EP0999849B1 (enExample) |
| JP (1) | JP2001509488A (enExample) |
| AT (1) | ATE223227T1 (enExample) |
| DE (2) | DE19729810C2 (enExample) |
| DK (1) | DK0999849T3 (enExample) |
| ES (1) | ES2183376T3 (enExample) |
| PT (1) | PT999849E (enExample) |
| WO (1) | WO1999002178A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2108372A1 (en) * | 2008-04-09 | 2009-10-14 | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften | Novel antimicrobial peptides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994025476A1 (en) * | 1993-04-30 | 1994-11-10 | Incyte Pharmaceuticals, Inc. | Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
| EP0664814A1 (en) * | 1993-08-18 | 1995-08-02 | MorphoSys AG | Lipopolysaccharide-binding and neutralizing peptides |
| WO1995008560A1 (en) * | 1993-09-24 | 1995-03-30 | Centocor, Inc. | Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp) |
| US5837810A (en) * | 1994-03-15 | 1998-11-17 | The Scripps Research Institute | Polypeptides of lipopolysaccharide binding protein |
| US5990082A (en) * | 1997-10-22 | 1999-11-23 | Xoma Corporation | Uses of lipopolysaccharide binding protein |
-
1997
- 1997-07-11 DE DE19729810A patent/DE19729810C2/de not_active Expired - Fee Related
-
1998
- 1998-04-04 PT PT98928139T patent/PT999849E/pt unknown
- 1998-04-04 WO PCT/DE1998/000964 patent/WO1999002178A1/de not_active Ceased
- 1998-04-04 AT AT98928139T patent/ATE223227T1/de not_active IP Right Cessation
- 1998-04-04 DE DE59805440T patent/DE59805440D1/de not_active Expired - Lifetime
- 1998-04-04 ES ES98928139T patent/ES2183376T3/es not_active Expired - Lifetime
- 1998-04-04 DK DK98928139T patent/DK0999849T3/da active
- 1998-04-04 EP EP98928139A patent/EP0999849B1/de not_active Expired - Lifetime
- 1998-04-04 JP JP2000501768A patent/JP2001509488A/ja active Pending
-
2000
- 2000-01-13 US US09/484,121 patent/US6949512B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE59805440D1 (de) | 2002-10-10 |
| WO1999002178A1 (de) | 1999-01-21 |
| JP2001509488A (ja) | 2001-07-24 |
| US6949512B1 (en) | 2005-09-27 |
| DE19729810A1 (de) | 1999-01-14 |
| DK0999849T3 (da) | 2003-01-06 |
| DE19729810C2 (de) | 2000-01-13 |
| EP0999849B1 (de) | 2002-09-04 |
| EP0999849A1 (de) | 2000-05-17 |
| ATE223227T1 (de) | 2002-09-15 |
| ES2183376T3 (es) | 2003-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0570916A3 (en) | Serum albumin, recombinant human, preparation process and pharmaceutical composition. | |
| CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| DK0914144T3 (da) | Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi | |
| BR9607317A (pt) | Peptídios e composição farmacêutica | |
| BR9607318A (pt) | Peptidos e composição farmacêutica | |
| NO985464L (no) | Konsentrert antistoffpreparat | |
| FI954978A7 (fi) | Modifioidut proteiini- ja peptidilääkeaineet | |
| NO980915D0 (no) | Rekombinante anti-CD4-antistoff egnet for human terapi | |
| DE69825625D1 (de) | Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen | |
| BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
| DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| DE69634489D1 (de) | Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon | |
| DE69714451D1 (de) | Prionbindende proteine und deren verwendungen | |
| ITMI942663A0 (it) | Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono | |
| FR2718451B1 (fr) | Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique. | |
| NZ500216A (en) | Beta-amyloid peptide-binding proteins and pharmaceutical use | |
| NO973292D0 (no) | On-line medikamentleveringssystem i ekstrakorporeal terapi | |
| DE69831084D1 (de) | Beta-defensine | |
| PT999849E (pt) | Utilizacao de lbp no tratamento da septicemia | |
| FI956353L (fi) | Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa | |
| NO980375D0 (no) | Humant MP52 Arg protein | |
| FI972965A7 (fi) | Uusia peptidejä, niiden valmistus ja käyttö | |
| TR199700842T1 (xx) | �nsan DNase I Varyantlar�. | |
| FI971085A7 (fi) | Uusia PKA:ta sitovia proteiineja ja näiden käyttömuotoja | |
| EE9800108A (et) | Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid |